This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
A U.S. state is enjoying $50 million in annual savings after imposing price caps on its hospitals. OK—but what good things (or workers) got sacrificed?
Every time an ambient AI vendor boasts about how many providers use its tool, a hungry lawyer gets a plum lead for a class-action lawsuit. And a lot of such lawyers are now on high alert for just such an opportunity to pounce.
Cardiologists often use the word “stable” when describing a heart failure patient who is recovering or showing signs of improvement. That word, however, could be giving patients a false sense of security—and it could even do harm to their long-term health.
The American public’s trust in healthcare institutions, long a matter of common courtesy, fell off a cliff after the COVID-19 crisis. Two academic physicians propose a treatment pathway for the injured patient—aka our healthcare system’s reputation for reliability.
Nearly 90% of adults are believed to already have at least one risk factor of CKM syndrome. The American Heart Association hopes patient education and physician collaborations can help increase awareness about this dangerous condition.
A facility outside the United States has received the American Heart Association's Comprehensive Heart Failure Center Certification for the first time.
Provider organizations are using generative AI for all sorts of use cases. It’s delivering impressive returns in two—tech support and patient experience.
A slow but sure approach to governance can keep AI champions focused on improving patient care when—and even after—the technology builds unstoppable momentum seemingly of its own accord.
Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value.
The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.
What good is AI in healthcare if it doesn’t improve financial margins? The question is getting posed in the C-suites of provider organizations and insurance companies.